Accès à distance ? S'identifier sur le proxy UCLouvain
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis : findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
Primary tabs
- Ginzler, N Engl J Med, 353, 2219 (2005)
- Grootscholten, Arthritis Rheum, 56, 924 (2007)
- Bezerra, Arthritis Rheum, 52, 3073 (2005)
- Ng, Ann Rheum Dis, 66, 1259 (2007)
- Gordon, Rheumatology (Oxford), 47, 334 (2008)
- Griffiths, Arthritis Rheum, 54, S789 (2006)
- Fortin, Arthritis Rheum, 59, 1796 (2008)
- Tam, Lupus, 13, 601 (2004)
- Wang, Lupus, 17, 638 (2008)
- Tam, Ann Rheum Dis, 65, 417 (2006)
- Crosbie, Cochrane Database Syst Rev, 17 (2007)
- Chatham, Arthritis Rheum, 58, S573 (2008)
- Wallace DJ, Lisse J, Stohl W, McKay J, Boling E, Merrill JT, et al. Belimumab (Bmab), a fully human monoclonal antibody to B-lymphocyte stimulator (Blys), shows bioactivity and reduces systemic lupus erythematosus disease activity. Proceedings of the Annual European Congress of Rheumatology (EULAR); 2006 June 21â24; Amsterdam, The Netherlands.
- Furie R, Lisse J, Merrill JT, Petri M, Ginzler E, Aranow C, et al. Multiple SLE disease activity measures in a multi-center phase 2 SLE trial demonstrate belimumab (fully human monoclonal antibody to B-lymphocyte stimulator [Blys]) improves or stabilizes SLE activity. Proceedings of the Annual European Congress of Rheumatology (EULAR); 2006 June 21â24; Amsterdam, The Netherlands.
- Mok, Scand J Rheumatol, 36, 329 (2007)
- Pisoni, J Rheumatol, 32, 1047 (2005)
- Gordon, Ann Rheum Dis, 68, 470 (2009)
- Hay, Q J Med, 86, 447 (1993)
- Isenberg, Lupus, 9, 651 (2000)
- Sinclair, Lupus, 16, 972 (2007)
- Appel, J Am Soc Nephrol, 20, 1103 (2009)
- Hochberg, Arthritis Rheum, 40, 1725 (1997)
- Weening, J Am Soc Nephrol, 15, 241 (2004)
- Austin, N Engl J Med, 314, 614 (1986)
- Brunner, Arthritis Rheum, 42, 1354 (1999)
- Ward, J Rheumatol, 27, 664 (2000)
- Isenberg, Rheumatology (Oxford), 44, 902 (2005)
- Yee, Arthritis Rheum, 54, 3300 (2006)
- Petri, Lupus, 8, 685 (1999)
- Gladman, Arthritis Rheum, 39, 363 (1996)
- Gladman, Arthritis Rheum, 40, 809 (1997)
- Alba, Lupus, 12, 633 (2003)
- Mak, Lupus, 14, 856 (2005)
- Mok, Ann Rheum Dis, 65, 971 (2006)
Bibliographic reference | Ginzler, Ellen M ; Wofsy, David ; Isenberg, David ; Gordon, Caroline ; Lisk, Laura ; et. al. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis : findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.. In: Arthritis and rheumatism, Vol. 62, no. 1, p. 211-221 (2010) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/105312 |